Cargando…
Ethical challenges in mass drug administration for reducing childhood mortality: a qualitative study
BACKGROUND: Mass drug administration (MDA) of medications to entire at-risk communities or populations has shown promise in the control and elimination of global infectious diseases. MDA of the broad-spectrum antibiotic azithromycin has demonstrated the potential to reduce childhood mortality in chi...
Autores principales: | Alasmar, Ahmed, Kong, Alex C., So, Anthony D., DeCamp, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482260/ https://www.ncbi.nlm.nih.gov/pubmed/36114588 http://dx.doi.org/10.1186/s40249-022-01023-6 |
Ejemplares similares
-
Meeting ethical challenges with authenticity when engaging patients and families in end-of-life and palliative care research: a qualitative study
por: DeCamp, Matthew, et al.
Publicado: (2022) -
Referrals, access, and equity of monoclonal antibodies for outpatient COVID-19: A qualitative study of clinician perspectives
por: Hamer, Mika K., et al.
Publicado: (2022) -
One drug to treat them all: ethical implications of the MORDOR trial of mass antibiotic administration to reduce child mortality
por: Tam, Clarence C, et al.
Publicado: (2019) -
Ethical considerations in an era of mass drug administration
por: Wharam, Barney, et al.
Publicado: (2013) -
Ethics and high-value care
por: DeCamp, Matthew, et al.
Publicado: (2017)